Inside Precision Medicine September 4, 2024
New research funded by the NIH National Heart, Lung, Blood Institute (NHLBI) has identified a combination of biomarkers that can predict a woman’s risk of developing cardiovascular disease over the next 30 years. The study, presented as late-breaking research at the European Society of Cardiology Congress 2024 and published in the New England Journal of Medicine, details how combining analysis of C-reactive protein (CRP), a measure of inflammation and two measures of lipids can help head off cardiovascular health problems decades in advance.
For their research, led by Paul M. Ridker, MD, director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital, the investigators collected blood samples and medical data from 27,939 female healthcare professionals in U.S....
Today's Sponsors
Today's Sponsor